 Edwards Lifesciences Corp NYSE: EW posted a Q1 adjusted EPS of 0.60, compared to 0.54 posted a year ago and beating the consensus of 0.57. Sales increased 10 to 1.34 billion underlying 13, beating the consensus of 1.31 billion. 